Systemic Lupus Erythematosus Clinical Trials

GSK Investigational Site
Birmingham Alabama 35216

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

539
Birmingham Alabama
Updated

Patients are needed to participate in a clinical research study evaluating Placebo and Epratuzumab for the treatment of Systemic Lupus Erythematosus

Research Site
Birmingham Alabama
Updated

Patients are needed to participate in a clinical research study of MEDI-546 and Placebo to evaluate Systemic Lupus Erythematosus

GSK Investigational Site
Huntsville Alabama 35801

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Pfizer Investigational Site
Oxford Alabama 36203

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

GSK Investigational Site
Phoenix Arizona 85016
Updated

Patients are needed to participate in a clinical research study of belimumab 10mg/kg and placebo to evaluate Systemic Lupus Erythematosus

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Scottsdale Arizona 85258

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tempe Arizona 85282

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Covina California 91723

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
El Cajon California 92020

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Escondido California 92027

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

085
Escondido California
Updated

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

579
Glendale California
Updated

Patients are needed to participate in a clinical research study evaluating Placebo and Epratuzumab for the treatment of Systemic Lupus Erythematosus

544
Huntington Beach California
Updated

Patients are needed to participate in a clinical research study evaluating Placebo and Epratuzumab for the treatment of Systemic Lupus Erythematosus

Unversity of California, Irvine Healthcare, Dermatology, Gottschalk Medical Plaza
Irvine California 92697

A clinical trial to evaluate treatments using IVIg for patients with Cutaneous Lupus Erythematosus

The Institute for Clinical and Translational Science (ICTS)
Irvine California 92697

A clinical trial to evaluate treatments using IVIg for patients with Cutaneous Lupus Erythematosus

Novo Nordisk Clinical Trial Call Center
La Jolla California 92093

A clinical research study of NNC0114-0006 and placebo for the treatment of Inflammation or Systemic Lupus Erythematosus

550
La Jolla California
Updated

Patients are needed to participate in a clinical research study evaluating Placebo and Epratuzumab for the treatment of Systemic Lupus Erythematosus

Research Site
La Jolla California
Updated

Patients are needed to participate in a clinical research study of MEDI-546 and Placebo to evaluate Systemic Lupus Erythematosus

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
La Mesa California 91941

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

GSK Investigational Site
La Mesa California 91942

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

GSK Investigational Site
La Palma California 90623

A clinical trial seeking patients for a research study for the treatment of Lupus Nephritis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Lakewood California 90712

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

Valerius Medical Group and Research Center
Long Beach California 90806

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus (SLE)

Research Site
Long Beach California
Updated

Patients are needed to participate in a clinical research study of MEDI-546 and Placebo to evaluate Systemic Lupus Erythematosus

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Los Alamitos California 90720

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Los Angeles California 90095

A clinical research study of LY2127399, Placebo every 2 weeks and Placebo every 4 weeks for the treatment of Systemic Lupus Erythematosus, Connective Tissue Disease or Autoimmune Disease

Wallace Rheumatic Study Center
Los Angeles California 90027

A clinical research study of R932333 and Placebo for the treatment of Lupus Erythematosus, Discoid or Lupus Erythematosus, Systemic

089
Los Angeles California
Updated

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

031
Los Angeles California
Updated

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

051
Los Angeles California
Updated

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Pfizer Investigational Site
Los Angeles California 90045

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Research Site
Los Angeles California 90048

Patients are needed to participate in a clinical research study of AMG 557 and Matching Placebo to evaluate Lupus Arthritis, Systemic Lupus Erythematosus

Research Site
Los Angeles California
Updated

Patients are needed to participate in a clinical research study of MEDI-546 and Placebo to evaluate Systemic Lupus Erythematosus